Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

NCT02802267 is registered in ClinicalTrials.gov with Hybrigenics Corporation as lead sponsor.

NCT NCT02802267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02802267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
Lead sponsor
Hybrigenics Corporation
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2019
Enrollment
110 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia